Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV Infections in Immunocompromised Adults
Condition: HSV Infection Interventions: Drug: Pritelivir; Drug: Foscarnet Injection [Foscavir] Sponsors: AiCuris Anti-infective Cures GmbH; Medpace, Inc. Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Condition: HSV Infection Interventions: Drug: Pritelivir; Drug: Foscarnet Injection [Foscavir] Sponsors: AiCuris Anti-infective Cures GmbH; Medpace, Inc. Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Condition: HSV Infection Interventions: Drug: Pritelivir; Drug: Foscarnet Sponsors: AiCuris Anti-infective Cures GmbH; Medpace, Inc. Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials